Nutriband Inc. (NTRB)
NASDAQ: NTRB · Real-Time Price · USD
5.83
+0.11 (1.92%)
At close: May 12, 2025, 4:00 PM
5.98
+0.15 (2.57%)
After-hours: May 12, 2025, 5:54 PM EDT
Nutriband Revenue
In the fiscal year ending January 31, 2025, Nutriband had annual revenue of $2.14M with 2.60% growth. Nutriband had revenue of $642.38K in the quarter ending January 31, 2025, with 22.45% growth.
Revenue (ttm)
$2.14M
Revenue Growth
+2.60%
P/S Ratio
28.36
Revenue / Employee
$164,580
Employees
13
Market Cap
64.84M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jan 31, 2025 | 2.14M | 54.22K | 2.60% |
Jan 31, 2024 | 2.09M | 5.71K | 0.27% |
Jan 31, 2023 | 2.08M | 657.46K | 46.23% |
Jan 31, 2022 | 1.42M | 478.45K | 50.70% |
Jan 31, 2021 | 943.70K | 573.06K | 154.61% |
Jan 31, 2020 | Pro | Pro | Pro |
Jan 31, 2019 | Pro | Pro | Pro |
Jan 31, 2018 | Pro | Pro | Pro |
Jan 31, 2017 | Pro | Pro | Pro |
Jan 31, 2016 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
NTRB News
- 12 days ago - Nutriband CEO Publishes Letter to Shareholders - GlobeNewsWire
- 4 weeks ago - Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology - GlobeNewsWire
- 5 weeks ago - UPDATE – Nutriband Signs Associate Partnership with Charlotte FC - GlobeNewsWire
- 5 weeks ago - Nutriband Signs Partnership Agreement with Charlotte FC - GlobeNewsWire
- 2 months ago - Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development. - GlobeNewsWire
- 3 months ago - Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch - GlobeNewsWire
- 3 months ago - Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™ - GlobeNewsWire
- 4 months ago - Nutriband Issues Letter to Shareholders - GlobeNewsWire